That compares with the 296 million franc median projection of five analysts surveyed by Bloomberg. Helvetia shares rose 1.5 percent to 350 francs as of 9:36 a.m in Zurich trading. "It is a 360 degree outstanding set of results," said Fabrizio Croce, a Zurich based analyst with Kepler Capital Markets SA who has a "buy" recommendation on the stock. "The real result is even stronger than the reported one.". 
Share:  That compares with the 296 million franc median projection of five analysts surveyed by Bloomberg. <span class="company">Helvetia</span> shares rose 1.5 percent to 350 francs as of 9:36 a.m in Zurich trading.<span class="sent"> "It is a 360 degree outstanding set of results," said <span class="analyst">Fabrizio Croce</span>, a Zurich based analyst with Kepler Capital Markets SA who has a "buy" recommendation on the stock.</span> "The real result is even stronger than the reported one.". Tweet this 

Swiss Life isn't "the right target for Allianz," said Fabrizio Croce, a Zurich based analyst with Kepler Capital Markets, in a note to investors this morning, adding that the Swiss competition commission would likely oppose a deal 
Share:  <span class="sent">Swiss Life isn't "the right target for <span class="company">Allianz</span>," said <span class="analyst">Fabrizio Croce</span>, a Zurich based analyst with Kepler Capital Markets, in a note to investors this morning, adding that the Swiss competition commission would likely oppose a deal</span> Tweet this 

Swiss Life isn't "the right target for Allianz," said Fabrizio Croce, a Zurich based analyst with Kepler Capital Markets, in a note to investors this morning, adding that the Swiss competition commission would likely oppose a deal 
Share:  <span class="sent"><span class="company">Swiss Life</span> isn't "the right target for Allianz," said <span class="analyst">Fabrizio Croce</span>, a Zurich based analyst with Kepler Capital Markets, in a note to investors this morning, adding that the Swiss competition commission would likely oppose a deal</span> Tweet this 

Swiss Life is however not the right target for Allianz," said Kepler Capital markets analyst Fabrizio Croce 
Share:  <span class="sent">Swiss Life is however not the right target for <span class="company">Allianz</span>," said Kepler Capital markets analyst <span class="analyst">Fabrizio Croce</span></span> Tweet this 

Swiss Life is however not the right target for Allianz," said Kepler Capital markets analyst Fabrizio Croce 
Share:  <span class="sent"><span class="company">Swiss Life</span> is however not the right target for Allianz," said Kepler Capital markets analyst <span class="analyst">Fabrizio Croce</span></span> Tweet this 

Swiss Life is however not the right target for Allianz," said Kepler Capital markets analyst Fabrizio Croce 
Share:  <span class="sent">Swiss Life is however not the right target for <span class="company">Allianz</span>," said Kepler Capital markets analyst <span class="analyst">Fabrizio Croce</span></span> Tweet this 

Swiss Life is however not the right target for Allianz," said Kepler Capital markets analyst Fabrizio Croce 
Share:  <span class="sent"><span class="company">Swiss Life</span> is however not the right target for Allianz," said Kepler Capital markets analyst <span class="analyst">Fabrizio Croce</span></span> Tweet this 

Swiss Re posted a surprise second quarter net loss on Wednesday as charges on corporate bond hedges, securitized products and its own credit spreads ate up operating returns. Zurich based Swiss Re said it made a net loss of 381 million Swiss francs ($359.1 million) after charges totalling 2.1 billion Swiss francs. That missed an average forecast for a net profit of 139 million in a Reuters poll of 12 analysts. "These results are only a warning shot, the start of the demonstration that earnings and capital are not what they seem," said Kepler Capital Markets analyst Fabrizio Croce.  
Share:  <span class="company">Swiss Re</span> posted a surprise second quarter net loss on Wednesday as charges on corporate bond hedges, securitized products and its own credit spreads ate up operating returns. Zurich based <span class="company">Swiss Re</span> said it made a net loss of 381 million Swiss francs ($359.1 million) after charges totalling 2.1 billion Swiss francs. That missed an average forecast for a net profit of 139 million in a Reuters poll of 12 analysts. <span class="sent"> "These results are only a warning shot, the start of the demonstration that earnings and capital are not what they seem," said Kepler Capital Markets analyst <span class="analyst">Fabrizio Croce</span>. </span>...<span class="company">Swiss Re</span> posted a surprise second quarter net loss on Wednesday as charges on corporate bond hedges, securitized products and its own credit spreads ate up operating returns. Zurich based <span class="company">Swiss Re</span> said it made a net loss of 381 million Swiss francs ($359.1 million) after charges totalling 2.1 billion Swiss francs. That missed an average forecast for a net profit of 139 million in a Reuters poll of 12 analysts. <span class="sent"> "These results are only a warning shot, the start of the demonstration that earnings and capital are not what they seem," said Kepler Capital Markets analyst <span class="analyst">Fabrizio Croce</span>. </span> The world's second biggest reinsurer said its excess capital at AA level had improved to 4.5 b Tweet this 

He added that the strengthening of the personal line business, where products are taken out by or for an individual, should make earnings less volatile. "The transaction shows that Zurich is able to take part in the consolidation and could hopefully benefit from the weakness of others on the back of the financial crises." But others said U.S expansion would not come easy. "The news is only slightly positive: the transaction is expensive and the U.S market one of the most difficult," said Kepler's analyst Fabrizio Croce.  
Share:  He added that the strengthening of the personal line business, where products are taken out by or for an individual, should make earnings less volatile. "The transaction shows that <span class="company">Zurich</span> is able to take part in the consolidation and could hopefully benefit from the weakness of others on the back of the financial crises." But others said U.S expansion would not come easy. <span class="sent"> "The news is only slightly positive: the transaction is expensive and the U.S market one of the most difficult," said Kepler's analyst <span class="analyst">Fabrizio Croce</span>. </span> Tweet this 

But that's not much of a surprise, as the company is stuck between a rock (growing hostility from the public) and a hard place (forced asset disposals). Fabrizio Croce, a Kepler Capital Markets analyst, told that Zurich should be careful not to overpay for the business, "especially as AIG is squeezed, as it has no choice ..and all its assets should therefore deflate further.". AIG has been working on several asset sales to help pay the government back. Here's where the assets sales stand so far: . Sold: Still for sale: . 
Share:  But that's not much of a surprise, as the company is stuck between a rock (growing hostility from the public) and a hard place (forced asset disposals). <span class="sent"> <span class="analyst">Fabrizio Croce</span>, a Kepler Capital Markets analyst, told that <span class="company">Zurich</span> should be careful not to overpay for the business, "especially as AIG is squeezed, as it has no choice ..and all its assets should therefore deflate further.". </span> AIG has been working on several asset sales to help pay the government back. Here's where the assets sales stand so far: . Sold: Still for sale: . Tweet this